Consolidated statements of income and comprehensive income / loss (–)
|
Year ended 31 December |
|
|
(thousands of €, except share and per share data) |
2018 |
2017 |
Notes |
Revenues |
288,836 |
127,087 |
|
Other income |
29,009 |
28,830 |
|
Total revenues and other income |
317,845 |
155,918 |
|
|
|
|
|
Research and development expenditure |
(322,875) |
(218,502) |
|
General and administrative expenses |
(35,631) |
(24,415) |
|
Sales and marketing expenses |
(4,146) |
(2,803) |
|
Total operating expenses |
(362,652) |
(245,720) |
|
|
|
|
|
Operating loss |
(44,807) |
(89,802) |
|
|
|
|
|
Financial income |
18,335 |
4,877 |
|
Financial expenses |
(2,737) |
(30,582) |
|
|
|
|
|
Loss before tax |
(29,209) |
(115,507) |
|
|
|
|
|
Income taxes |
(50) |
(198) |
|
|
|
|
|
Net loss |
(29,259) |
(115,704) |
|
Net loss attributable to: |
|
|
|
Owners of the parent |
(29,259) |
(115,704) |
|
Basic & diluted loss per share |
(0.56) |
(2.34) |
|
|
Year ended 31 December |
|
|
(thousands of €) |
2018 |
2017 |
Notes |
Net loss |
(29,259) |
(115,704) |
|
Items that will not be reclassified subsequently to profit or loss: |
|
|
|
Re-measurement of defined benefit obligation |
(94) |
(40) |
|
Items that may be reclassified subsequently to profit or loss: |
|
|
|
Fair value adjustment of available-for-sale financial assets |
– |
(220) |
|
Translation differences, arisen from translating foreign activities |
197 |
(664) |
|
Other comprehensive income / loss (-), net of income tax |
103 |
(924) |
|
|
|
|
|
Total comprehensive loss attributable to: |
|
|
|
Owners of the parent |
(29,155) |
(116,629) |
|